Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Alpine Immune Sciences Inc Stock

Price
Target price
€60.50

€60.50

-0.830%
-0.5
-0.830%
-
 
03.05.24 / Tradegate WKN: A2DU89 / Name: Alpine Immune Sciences / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Alpine Immune Sciences Inc in the next few years
Wizard

Description Alpine Immune Sciences

Alpine Immune Sciences is a publicly traded biopharmaceutical company headquartered in Seattle, Washington. It is focused on developing immunotherapy drugs to treat cancer and autoimmune diseases. The company's platform technology, called Variant Immunoglobulin Domain (vIgD), allows the design of novel protein therapeutics that can bind to immune system targets with high affinity and specificity.

Alpine Immune Sciences is currently conducting clinical trials for its lead drug candidate, ALPN-101, which is being developed as a treatment for autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. The company has also collaborated with pharmaceutical companies such as AbbVie and Kite Pharma to develop immunotherapy drugs for cancer.

As of August 2021, Alpine Immune Sciences is traded on the NASDAQ stock exchange under the ticker symbol "ALPN". Its market capitalization is approximately $185 million.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Alpine Immune Sciences Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Alpine Immune Sciences

sharewise wants to provide you with the best news and tools for Alpine Immune Sciences, so we directly link to the best financial data sources.

Financials

News

Broker